DOI: https://doi.org/10.22141/2224-1485.3-4.64-65.2019.177854

False controlled arterial hypertension: cognitive functions and quality of life

V.Yu. Krotova

Abstract


The article presents the results of neuropsychological examination of 509 outpatients with a controlled stage II arterial hypertension and an integrated assessment of cognitive functions using the Mini-Mental State Examination and Montreal Cognitive Assessment. It was found that 32.2 % of persons with a controlled stage II arterial hypertension and a low cardiovascular risk on SCORE scale had non-dementia cognitive disorders that became the basis for considering controlled arterial hypertension in such patients with cognitive impairment as false. In patients with hypertension and cognitive disorders, based on the data on the SF-36 questionnaire, there was a significant (p < 0.001) decrease in quality of life on all sections compared to those without cognitive disorders and healthy ones. Risk factors for the development of cognitive impairment in hypertension are history of cognitive disorders in the immediate family, as well as variability of systolic blood pressure above 12 mmHg during the day according to ambulatory blood pressure monitoring and daytime diastolic blood pressure — above 10 mmHg. The results of the correlation analysis revealed a direct relationship between the deterioration in the quality of life components and impaired cognitive functions assessed by various neuropsychological tests. An early determination of the indicators of cognitive function in patients with stage II arterial hypertension as a marker of brain damage due to arterial hypertension is necessary to clarify the risk stratification for cardiovascular events.

Keywords


arterial hypertension; daily blood pressure profile; cognitive functions; quality of life

References


Coca A., Monteagudo E., Domnech M., Camafort M., Sierra C. Can the Treatment of Hypertension in the Middle-Aged Prevent Dementia in the Elderly? High Blood Press Cardiovasc. Prev. 2016. 23(2). 97-104.

Johnson M.L., Parikh N., Kunik M.E., Schulz P.E., Patel J.G., Chen H. et al. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimer’s & Dementia. 2012. 8(5). 437-444. doi:10.1016/j.jalz.2011.05.2414.

Kelly M.E., Duff H., Kelly S., McHugh Power J.E., Brennan S., Lawlor B.A. et al. The impact of social activities, social networks, social support and social relationships on the cognitive functioning of healthy older adults: a systematic review. Systematic Reviews. 2017. 6(1). 259. doi:10.1186/s13643-017-0632-2.

Mancia G., Fagard R., Narkiewicz K. et al. ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 2013. Vol. 34(28). P. 2159-2219.

Risk reduction of cognitive decline and dementia: WHO guidelines. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.

Williams B., Mancia G., Spiering W., Agabiti Rosei E., Sirenko Y., Brady A. et al. ESC-ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018. 39. 3021-3104.




Copyright (c) 2019 HYPERTENSION

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2020

 

   Seo анализ сайта